WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2005122791) IMPROVEMENT OF BARRIER INTEGRITY IN HIV PATIENTS WITH FATTY ACIDS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2005/122791    International Application No.:    PCT/NL2005/000451
Publication Date: 29.12.2005 International Filing Date: 22.06.2005
Chapter 2 Demand Filed:    24.04.2006    
IPC:
A23L 1/30 (2006.01), A23L 1/308 (2006.01), A61P 31/18 (2006.01), A61K 31/201 (2006.01), A61K 31/202 (2006.01)
Applicants: N.V. NUTRICIA [NL/NL]; Eerste Stationsstraat 186, NL-2712 HM Zoetermeer (NL) (For All Designated States Except US).
VAN TOL, Eric, Alexander, Franciscus [NL/NL]; (NL) (For US Only).
WILLEMSEN, Linette, Eustachia, Maria [NL/NL]; (NL) (For US Only).
KOETSIER, Marleen, Antoinette [NL/NL]; (NL) (For US Only).
BEERMANN, Christopher [DE/DE]; (DE) (For US Only).
STAHL, Bernd [DE/DE]; (DE) (For US Only)
Inventors: VAN TOL, Eric, Alexander, Franciscus; (NL).
WILLEMSEN, Linette, Eustachia, Maria; (NL).
KOETSIER, Marleen, Antoinette; (NL).
BEERMANN, Christopher; (DE).
STAHL, Bernd; (DE)
Agent: VAN WESTENBRUGGE, Andries; Nederlandsch Octrooibureau, P.O. Box 29720, NL-2502 LS The Hague (NL)
Priority Data:
PCT/NL2004/000444 22.06.2004 NL
05103257.1 21.04.2005 EP
05103260.5 21.04.2005 EP
Title (EN) IMPROVEMENT OF BARRIER INTEGRITY IN HIV PATIENTS WITH FATTY ACIDS
(FR) AMELIORATION DE L'INTEGRITE DE LA BARRIERE INTESTINALE CHEZ LES PATIENTS ATTEINTS DE VIH
Abstract: front page image
(EN)The invention concerns a method for stimulating intestinal barrier integrity in a patient infected with HIV by administering to said patient composition comprising: eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA) and arachidonic acid (ARA), and at least two distinct oligosaccharides.
(FR)L'invention concerne une méthode de stimulation de l'intégrité de la barrière intestinale chez un patient infecté par le VIH, consistant à administrer audit patient une composition contenant de l'acide éicosapentaénoïque (EPA), de l'acide docosahexaénoïque (DHA) et de l'acide arachidonique (ARA), et au moins deux oligosaccharides distincts.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)